Immune checkpoints, such as Programmed death receptor 1/programmed death receptor-ligand 1 (PD-1/PD-L1), which normally maintain immune balance by modulating microglial activation and limiting excessive inflammation, also become dysfunctional in AD, further perpetuating neuroinflammation [215, 216]. Here, CD274 is linked to Alzheimer disease.